 | • レポートコード：QY20ST-06967 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の変形性関節症薬市場について種類別（経口、注射、外用）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・変形性関節症薬市場の概要 ・世界の主要地域別変形性関節症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の変形性関節症薬市場規模2015-2026：種類別（経口、注射、外用） ・世界の変形性関節症薬市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・変形性関節症薬の北米市場規模2015-2020 ・変形性関節症薬のヨーロッパ市場規模2015-2020 ・変形性関節症薬の中国市場規模2015-2020 ・変形性関節症薬の日本市場規模2015-2020 ・変形性関節症薬の東南アジア市場規模2015-2020 ・変形性関節症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・変形性関節症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・変形性関節症薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Osteoarthritis Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Osteoarthritis Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Osteoarthritis Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Osteoarthritis Drugs industry.
Based on our recent survey, we have several different scenarios about the Osteoarthritis Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 5385.9 million in 2019. The market size of Osteoarthritis Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Osteoarthritis Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Osteoarthritis Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Osteoarthritis Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Osteoarthritis Drugs market. The report also includes nautical information, where it shows Osteoarthritis Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Osteoarthritis Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Osteoarthritis Drugs market.
Geographical Analysis:
Based on region, the global Osteoarthritis Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Osteoarthritis Drugs market are
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics
…
Segment by Type
Oral
Injection
External
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Osteoarthritis Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Osteoarthritis Drugs market.
• The market share of the global Osteoarthritis Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Osteoarthritis Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Osteoarthritis Drugs market.
1 Osteoarthritis Drugs Market Overview
1.1 Osteoarthritis Drugs Product Scope
1.2 Osteoarthritis Drugs Segment by Type
1.2.1 Global Osteoarthritis Drugs Sales by Type (2020-2026)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Osteoarthritis Drugs Segment by Application
1.3.1 Global Osteoarthritis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Osteoarthritis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Osteoarthritis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Osteoarthritis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Osteoarthritis Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Osteoarthritis Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Osteoarthritis Drugs Industry
1.5.1.1 Osteoarthritis Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Osteoarthritis Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Osteoarthritis Drugs Players to Combat Covid-19 Impact
2 Osteoarthritis Drugs Estimate and Forecast by Region
2.1 Global Osteoarthritis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Osteoarthritis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Osteoarthritis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Osteoarthritis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Osteoarthritis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Osteoarthritis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Osteoarthritis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Osteoarthritis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Osteoarthritis Drugs Estimates and Projections (2015-2026)
2.4.3 China Osteoarthritis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Osteoarthritis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Osteoarthritis Drugs Estimates and Projections (2015-2026)
2.4.6 India Osteoarthritis Drugs Estimates and Projections (2015-2026)
3 Global Osteoarthritis Drugs Competition Landscape by Players
3.1 Global Top Osteoarthritis Drugs Players by Sales (2015-2020)
3.2 Global Top Osteoarthritis Drugs Players by Revenue (2015-2020)
3.3 Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Drugs as of 2019)
3.4 Global Osteoarthritis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Osteoarthritis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Osteoarthritis Drugs Players (Opinion Leaders)
4 Global Osteoarthritis Drugs Market Size by Type
4.1 Global Osteoarthritis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Osteoarthritis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Osteoarthritis Drugs Price by Type (2014-2020)
4.2 Global Osteoarthritis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Osteoarthritis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Osteoarthritis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Osteoarthritis Drugs Price Forecast by Type (2021-2026)
5 Global Osteoarthritis Drugs Market Size by Application
5.1 Global Osteoarthritis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Osteoarthritis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Osteoarthritis Drugs Price by Application (2015-2020)
5.2 Global Osteoarthritis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Osteoarthritis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Osteoarthritis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Osteoarthritis Drugs Price Forecast by Application (2021-2026)
3 North America Osteoarthritis Drugs Market Facts & Figures
3.2 North America Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
3.3 North America Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
3.4 North America Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
4 Europe Osteoarthritis Drugs Market Facts & Figures
4.2 Europe Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
5 China Osteoarthritis Drugs Market Facts & Figures
5.2 China Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
5.3 China Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
5.4 China Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
6 Japan Osteoarthritis Drugs Market Facts & Figures
6.2 Japan Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Osteoarthritis Drugs Market Facts & Figures
7.2 Southeast Asia Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
8 India Osteoarthritis Drugs Market Facts & Figures
8.2 India Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
8.3 India Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
8.4 India Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Osteoarthritis Drugs Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Osteoarthritis Drugs Corporation Information
12.1.2 Johnson & Johnson Osteoarthritis Drugs Business Overview and Total Revenue
12.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson & Johnson Osteoarthritis Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Pfizer
12.2.1 Pfizer Osteoarthritis Drugs Corporation Information
12.2.2 Pfizer Osteoarthritis Drugs Business Overview and Total Revenue
12.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Osteoarthritis Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Osteoarthritis Drugs Corporation Information
12.3.2 Eli Lilly Osteoarthritis Drugs Business Overview and Total Revenue
12.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly Osteoarthritis Drugs Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Abbott
12.4.1 Abbott Osteoarthritis Drugs Corporation Information
12.4.2 Abbott Osteoarthritis Drugs Business Overview and Total Revenue
12.4.3 Abbott Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Osteoarthritis Drugs Products Offered
12.4.5 Abbott Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Osteoarthritis Drugs Corporation Information
12.5.2 GlaxoSmithKline Osteoarthritis Drugs Business Overview and Total Revenue
12.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Osteoarthritis Drugs Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Sanofi
12.6.1 Sanofi Osteoarthritis Drugs Corporation Information
12.6.2 Sanofi Osteoarthritis Drugs Business Overview and Total Revenue
12.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Osteoarthritis Drugs Products Offered
12.6.5 Sanofi Recent Development
12.7 Flexion Therapeutics
12.7.1 Flexion Therapeutics Osteoarthritis Drugs Corporation Information
12.7.2 Flexion Therapeutics Osteoarthritis Drugs Business Overview and Total Revenue
12.7.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Flexion Therapeutics Osteoarthritis Drugs Products Offered
12.7.5 Flexion Therapeutics Recent Development
…
13 Osteoarthritis Drugs Manufacturing Cost Analysis
13.1 Osteoarthritis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Osteoarthritis Drugs
13.4 Osteoarthritis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Osteoarthritis Drugs Distributors List
14.3 Osteoarthritis Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Osteoarthritis Drugs Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Osteoarthritis Drugs Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Osteoarthritis Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Osteoarthritis Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Osteoarthritis Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Osteoarthritis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Osteoarthritis Drugs Sales (MT) by Region (2015-2020)
Table 10. Global Osteoarthritis Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Osteoarthritis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Osteoarthritis Drugs Revenue Share by Region (2015-2020)
Table 13. Global Osteoarthritis Drugs Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Osteoarthritis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Osteoarthritis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Osteoarthritis Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Osteoarthritis Drugs (MT) of Key Companies (2015-2020)
Table 18. Global Osteoarthritis Drugs Sales Share by Company (2015-2020)
Table 19. Global Osteoarthritis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Osteoarthritis Drugs Revenue Share by Company (2015-2020)
Table 21. Global Osteoarthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoarthritis Drugs as of 2019)
Table 22. Global Osteoarthritis Drugs Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Osteoarthritis Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Osteoarthritis Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Osteoarthritis Drugs Players
Table 27. Global Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 28. Global Osteoarthritis Drugs Sales Share by Type (2015-2020)
Table 29. Global Osteoarthritis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Osteoarthritis Drugs Price (MT) by Type (2015-2020)
Table 31. Global Osteoarthritis Drugs Sales Share by Type (2021-2026)
Table 32. Global Osteoarthritis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Osteoarthritis Drugs Revenue Share by Type (2021-2026)
Table 34. Global Osteoarthritis Drugs Price (MT) by Type (2021-2026)
Table 35. Global Osteoarthritis Drugs Sales (MT) by Application (2015-2020)
Table 36. Global Osteoarthritis Drugs Sales Share by Application (2015-2020)
Table 37. Global Osteoarthritis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Osteoarthritis Drugs Price (MT) by Application (2015-2020)
Table 39. Global Osteoarthritis Drugs Sales (MT) by Application (2021-2026)
Table 40. Global Osteoarthritis Drugs Sales Share by Application (2021-2026)
Table 41. Global Osteoarthritis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Osteoarthritis Drugs Revenue Share by Application (2021-2026)
Table 43. Global Osteoarthritis Drugs Price (MT) by Application (2021-2026)
Table 44. United States Osteoarthritis Drugs Sales (MT) by Company (2015-2020)
Table 45. United States Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 47. United States Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Osteoarthritis Drugs Sales (MT) by Application (2015-2020)
Table 49. United States Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Osteoarthritis Drugs Sales (MT) by Company (2015-2020)
Table 51. Europe Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 53. Europe Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Osteoarthritis Drugs Sales (MT) by Application (2015-2020)
Table 55. Europe Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 56. China Osteoarthritis Drugs Sales (MT) by Company (2015-2020)
Table 57. China Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
Table 58. China Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 59. China Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 60. China Osteoarthritis Drugs Sales (MT) by Application (2015-2020)
Table 61. China Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Osteoarthritis Drugs Sales (MT) by Company (2015-2020)
Table 63. Japan Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 65. Japan Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Osteoarthritis Drugs Sales (MT) by Application (2015-2020)
Table 67. Japan Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Osteoarthritis Drugs Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
Table 74. India Osteoarthritis Drugs Sales (MT) by Company (2015-2020)
Table 75. India Osteoarthritis Drugs Sales Market Share by Company (2015-2020)
Table 76. India Osteoarthritis Drugs Sales (MT) by Type (2015-2020)
Table 77. India Osteoarthritis Drugs Sales Market Share by Type (2015-2020)
Table 78. India Osteoarthritis Drugs Sales (MT) by Application (2015-2020)
Table 79. India Osteoarthritis Drugs Sales Market Share by Application (2015-2020)
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Osteoarthritis Drugs Product
Table 84. Johnson & Johnson Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Pfizer Osteoarthritis Drugs Product
Table 89. Pfizer Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Eli Lilly Osteoarthritis Drugs Product
Table 94. Eli Lilly Recent Development
Table 95. Abbott Corporation Information
Table 96. Abbott Description and Business Overview
Table 97. Abbott Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Abbott Osteoarthritis Drugs Product
Table 99. Abbott Recent Development
Table 100. GlaxoSmithKline Corporation Information
Table 101. GlaxoSmithKline Description and Business Overview
Table 102. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. GlaxoSmithKline Osteoarthritis Drugs Product
Table 104. GlaxoSmithKline Recent Development
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Sanofi Osteoarthritis Drugs Product
Table 109. Sanofi Recent Development
Table . Flexion Therapeutics Corporation Information
Table . Flexion Therapeutics Description and Business Overview
Table . Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Flexion Therapeutics Osteoarthritis Drugs Product
Table . Flexion Therapeutics Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Osteoarthritis Drugs Distributors List
Table 118. Osteoarthritis Drugs Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Osteoarthritis Drugs Product Picture
Figure 2. Global Osteoarthritis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Osteoarthritis Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Osteoarthritis Drugs Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Osteoarthritis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Osteoarthritis Drugs Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Osteoarthritis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Osteoarthritis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Osteoarthritis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Osteoarthritis Drugs Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Osteoarthritis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Osteoarthritis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Osteoarthritis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Osteoarthritis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Osteoarthritis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Osteoarthritis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Osteoarthritis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Osteoarthritis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Osteoarthritis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Osteoarthritis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Osteoarthritis Drugs Players Market Share by Revenue in Osteoarthritis Drugs 2015 & 2019
Figure 27. Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Osteoarthritis Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Osteoarthritis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Osteoarthritis Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Osteoarthritis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 33. United States Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 34. Europe Osteoarthritis Drugs Sales Market Share by Company in 2019
Figure 35. Europe Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 36. Europe Osteoarthritis Drugs Sales Market Share by Application in 2019
Figure 37. China Osteoarthritis Drugs Sales Market Share by Company in 2019
Figure 38. China Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 39. China Osteoarthritis Drugs Sales Market Share by Application in 2019
Figure 40. Japan Osteoarthritis Drugs Sales Market Share by Company in 2019
Figure 41. Japan Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 42. Japan Osteoarthritis Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Osteoarthritis Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Osteoarthritis Drugs Sales Market Share by Application in 2019
Figure 46. India Osteoarthritis Drugs Sales Market Share by Company in 2019
Figure 47. India Osteoarthritis Drugs Sales Market Share by Type in 2019
Figure 48. India Osteoarthritis Drugs Sales Market Share by Application in 2019
Figure 49. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Flexion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Osteoarthritis Drugs
Figure 58. Manufacturing Process Analysis of Osteoarthritis Drugs
Figure 59. Osteoarthritis Drugs Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
変形性関節症薬の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- 変形性膝関節症用関節内補充療法の世界市場レポート2020 A recently published report by QY Research titled Global Viscosupplementation for Knee Osteoarthritis Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stati…
- 皮膚炎薬の世界市場レポート2020 A recently published report by QY Research titled Global Dermatitis Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate d…
- 抗線維化薬の世界市場レポート2020 A recently published report by QY Research titled Global Antifibrotic Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…
- 幹細胞薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Stem Cell Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stem Cell Drugs market report…